Alnylam Q3 Net Income Rises to $2.17 Billion
Story updates
12:12:05 PM UTC
SquawkNews
Alnylam: Q3-Nettogewinn steigt gegenüber Vorjahr auf 2.17 Milliarden US-Dollar; Q3-Umsatz klettert u
12:20:55 PM UTC
SquawkNews
Alnylam Pharmaceuticals Q3 revenue rises on AMVUTTRA demand
12:21:35 PM UTC
SquawkNews
Alnylam Pharmaceuticals reported revenue of $1.46B and net income of $2.17B for the 2026 reporting period, compared with $1.25B and $292.68M, respectively, a year earlier. Diluted EPS was $15.72, up from $2.14.Financial Highlights¹ Reported as “Total revenues”. ² Reported as “Net income”. ³ Reporte…
12:23:31 PM UTC
SquawkNews
Alnylam reported third-quarter 2026 revenue of $1.46 billion, up 17% year over year, and net income of $2.17 billion. Net product revenue increased 52%, led by AMVUTTRA, while operating income was $345.8 million. The company reiterated its 2026 financial guidance.Financial HighlightsBusiness Highli…